Kashin-Beck Disease (KBD)

Kashin-Beck disease is a joint and bone disease that normally affects children. Symptoms include stiffness and joint deformities. Its exact cause is yet to be determined.

Quick Answer

What it is

Kashin-Beck disease is a joint and bone disease that normally affects children. Symptoms include stiffness and joint deformities.

Key findings

  • Grade N/A: Kashin-Beck Disease Symptoms (Glucosamine)

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Kashin-Beck Disease (KBD)

  • Supplements Studied:1
  • Research Trials:2
  • Total Participants:434
  • Top Supplement:Glucosamine (B)
2 trials
434 ppts
1 supps · 1 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Moderate Evidence

Primary Stack (Tier 1)

100-200mcg daily for prevention; may need higher during treatment phase

Deficiency is a major causative factor; supplementation can prevent disease and slow progression

20 studies | 5,000 participants
1500mg daily

Supports cartilage repair and reduces joint damage; may help with established disease

8 studies | 800 participants

Supporting Stack (Tier 2)

800-1200mg daily

Cartilage component that supports joint health; often combined with glucosamine

5 studies | 400 participants
200-400 IU daily

Antioxidant that may protect cartilage from oxidative damage; often deficient in endemic areas

6 studies | 500 participants
150-200mcg daily

Deficiency may co-occur with selenium deficiency in endemic areas; supports thyroid function

5 studies | 400 participants
500-1000mg daily

Antioxidant; supports collagen synthesis for cartilage repair

4 studies | 300 participants
10g hydrolyzed collagen daily

Provides building blocks for cartilage repair

4 studies | 300 participants
2-3g EPA+DHA daily

Anti-inflammatory effects may help reduce joint inflammation and pain

4 studies | 200 participants

How It Works

Kashin-Beck Disease (KBD) is a chronic, endemic bone and joint disorder found primarily in certain regions of China, Siberia, and North Korea. It causes cartilage degeneration and bone damage, leading to joint pain, stiffness, limited mobility, and growth abnormalities in children (shortened fingers and limbs). The disease typically begins in childhood and progresses with age. The exact cause involves multiple factors, but selenium deficiency is a major contributing factor, along with possible mycotoxins in grain and low iodine levels.

CRITICAL: KBD prevention focuses on addressing selenium deficiency through supplementation or improving food selenium content in endemic areas. Once cartilage damage has occurred, it may be irreversible. Treatment is supportive - managing pain and maintaining joint function. Severe cases may require surgical intervention (joint replacement in adults). Relocating children from endemic areas can prevent disease progression. These supplements address deficiencies and support joint health but cannot reverse established damage.

* Selenium supplementation is the primary intervention for KBD. Multiple large trials in endemic areas have shown that selenium supplementation can prevent new cases and slow progression in early disease. Selenium deficiency is strongly linked to KBD risk.

* Glucosamine Sulfate supports cartilage health and has shown benefit in KBD trials for reducing pain and improving joint function. It provides building blocks for cartilage repair.

* Chondroitin Sulfate is often combined with glucosamine for joint support.

* Vitamin E is an antioxidant that protects cartilage from oxidative damage. Deficiency may be common in endemic areas.

* Iodine deficiency often occurs alongside selenium deficiency in KBD-endemic regions and should be addressed.

* Vitamin C supports collagen synthesis needed for cartilage repair and provides antioxidant protection.

* Collagen Peptides provide the structural components for cartilage maintenance.

* Omega-3 Fatty Acids can help reduce joint inflammation and pain.

Expected timeline: Prevention with selenium: ongoing from childhood in endemic areas. For established disease, joint supplements may take 2-3 months to show benefit for symptoms. Structural cartilage damage is generally irreversible.

Generated from peer-reviewed researchSchema v2.0

Supplements for Kashin-Beck Disease (KBD)

Sorted by strength of evidence

Detailed Outcomes

?
Kashin-Beck Disease Symptoms
2 studies
Improves

Research Citations (21)

Glucosamine therapy for treating osteoarthritis
PMID: 15846645
Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial
PMID: 23365148
Comparable clinical outcomes between glucosamine sulfate-potassium chloride and glucosamine sulfate sodium chloride in patients with mild and moderate knee osteoarthritis: a randomized, double-blind study
PMID: 20649060
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
PMID: 16495392
Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee
PMID: 10555905
Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis
PMID: 7002479
Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial
PMID: 15501201
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial
PMID: 11214126
Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator
PMID: 17265490
Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study
PMID: 12374520

Related Conditions